SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-036650
Filing Date
2020-02-14
Accepted
2020-02-14 07:12:28
Documents
2
Period of Report
2020-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d888676d8k.htm 8-K 18974
2 EX-99.1 d888676dex991.htm EX-99.1 9315
  Complete submission text file 0001193125-20-036650.txt   29501
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38906 | Film No.: 20613832
SIC: 2836 Biological Products, (No Diagnostic Substances)